z-logo
open-access-imgOpen Access
Rotavirus A infections and reinfections: genotyping and vaccine implications
Author(s) -
Paulo Sucasas Costa,
D. D. P. Cardoso,
Sandra Josefina Ferraz Ellero Grisi,
Paula Amador Gomes da Silva,
Fabíola Souza Fiaccadori,
Menira Souza,
Rodrigo Alessandro Tôgo Santos
Publication year - 2004
Publication title -
jornal de pediatria
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.645
H-Index - 52
eISSN - 1678-4782
pISSN - 0021-7557
DOI - 10.2223/jped.1150
Subject(s) - rotavirus , genotyping , diarrhea , medicine , feces , genotype , acute diarrhea , rotavirus vaccine , virology , pediatrics , gastroenterology , biology , microbiology and biotechnology , genetics , gene
OBJECTIVETo identify rotavirus A and the most prevalent G and P genotypes in children with acute diarrhea, and to the describe the occurrence of rotavirus infection and reinfection.METHODSGroup A rotavirus specimens were obtained from fecal samples from children with acute diarrhea in Goiânia, state of Goiás, Brazil from July 2000 to October 2002. Rotavirus A positive children and a control group (children of the same age and sex, without diarrhea and with no evidence of rotavirus in the first fecal samples) were followed prospectively during one year. All rotavirus A positive samples were genotyped using RT-PCR/nested-PCR.RESULTSA total of 77 group A rotavirus strains (37.2%) were identified in the diarrheic samples of 207 children. The following G genotypes were identified: G1 (62.3%), G9 (34.4%) and G4 (3.3%). With regard to P genotyping, 59% were characterized as P[8], 7.7% as P[6], 23.1% as P[6]+P[8], 7.7% as P[4]+P[8] and 2.6% as P[4]+P[8]. The following associations were observed: G1P[8] (77.8%), G9P[8] (11.1%), G4P[8] (5.6%) and G1P[6] (5.6%). No reinfection was observed in the 40 rotavirus A (+) children. However, but two of 40 children who were initially negative for this agent developed rotavirus infection during the same period.CONCLUSIONSThe predominant G and P genotypes observed were similar to those found in new vaccines. No reinfection occurred during one-year of follow-up for any of the genotypes identified.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom